Join our journey – Nordic Transport Group goes public

NTG was founded in 2011 with a vision of becoming a leading Northern European transportation company by attracting the most skilled, ambitious and hard-working people in industry.

That goal has been achieved. Through double-digit organic growth and 20 acquisitions, NTG now operates in 30 countries with c. 1,340 employees. From 2015 to 2018, revenue grew by 38% per year on average and we expect to increase last year’s revenue of DKK 4.5 billion to DKK 5.0-5.5 billion in 2019 and realise an adjusted EBIT of DKK 200-215 million.

But it does not end here. We operate in a vast global market with ample opportunities to continue our growth by strengthening our European presence in Road & Logistics and expanding our Air & Ocean division to become a truly global transportation partner.

Our indirect initial public offering through NeuroSearch on Nasdaq Copenhagen allows us to build on our success and take Nordic Transport Group to the next level.

The journey has only just begun.

Contact: Christian Jakobsen, Group CFO +45 7632 0989 or ir@ntg.dk

The information contained in this section of the website of Nordic Transport Group A/S is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”), Australia, Canada or Japan, or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

OK

The information contained in this section of the website of Nordic Transport Group A/S (the “Company”) is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the “United States”), Australia, Canada or Japan, or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction, and does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Company or NeuroSearch A/S in the United States, Australia, Canada or Japan, or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction. The shares referred to on this website (the “Shares”) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold within the United States absent registration or pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Access to the information and documents contained on the following websites may be illegal in certain jurisdictions, and only certain categories of persons may be authorised to access such information and documents. All persons residing outside of Denmark who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside Denmark. Neither the Company nor NeuroSearch A/S assumes any responsibility if there is a violation of applicable law and regulations by any person.

I therefore certify that:
1. I am resident and physically present outside the United States, Australia, Canada and Japan; and
2. I am authorised to access the information and documents on this website without being subject to any legal restriction and without any further action required by the Company.

I have read, understand and agree to comply with all of the restrictions set forth above.

THE ACCESS TO THE INFORMATION AND DOCUMENTS CONTAINED IN THIS SECTION OF NORDIC TRANSPORT GROUP A/S’ (THE “COMPANY”) WEBSITE IS LIMITED TO PERSONS RESIDENT AND PHYSICALLY PRESENT IN DENMARK AND TO AUTHORISED PERSONS WHO ARE RESIDENT AND PHYSICALLY PRESENT IN CERTAIN OTHER JURISDICTIONS. THE INFORMATION IS MADE AVAILABLE IN CONNECTION WITH THE PUBLIC OFFERING OF SHARES IN NEUROSEARCH A/S (THE “ISSUER”) WHICH COMPRISES (I) A PUBLIC OFFERING TO RETAIL AND INSTITUTIONAL INVESTORS IN DENMARK and (II) PRIVATE PLACEMENTS TO INSTITUTIONAL INVESTORS IN CERTAIN OTHER JURISDICTIONS. THE OFFERING HAS NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THERE IS NO INTENTION TO REGISTER ANY SECURITIES REFERRED TO HEREIN IN THE UNITED STATES OR TO MAKE A PUBLIC OFFERING OF THE SECURITIES IN THE UNITED STATES. THE INFORMATION AND DOCUMENTS MUST NOT BE ACCESSED, COPIED OR DOWNLOADED, IN WHOLE OR IN PART, TO PERSONS RESIDENT IN ANY JURISDICTION WHERE AN OFFER TO SELL OR A SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES ISSUED BY THE COMPANY WOULD BE UNLAWFUL AND THE INFORMATION AND DOCUMENTS CONTAINED HEREIN ARE NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO SUCH JURISDICTIONS. All persons residing outside of Denmark who wish to have access to the information and the documents contained in this section of the Company’s website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. No such registration or approval has been obtained outside Denmark. Neither the Company nor the Issuer assumes any responsibility if there is a violation of applicable law and regulations by any person. In any member state of the European Economic Area (“EEA Member State”), other than Denmark, the information and the documents contained in this section of the Company’s website are only addressed to and are only directed at investors in that EEA Member State who fulfil the criteria for exemption from the obligation to publish a prospectus, including qualified investors within the meaning of EU Regulation 2017/1129 on prospectuses. Any securities referred to in this section of the Company’s website have not been and will not be registered under the Securities Act, and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. In the United Kingdom, this announcement and any other materials in relation to the securities described herein are only being distributed to, and is only directed at, and any investment or investment activity to which the Prospectus relates is available only to, and will be engaged in only with persons who are (i) investment professionals falling within Article 19(5); (i) falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations, etc.”), of the U.K. Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended; or (iii) are high net worth bodies corporate, unincorporated associations and partnerships and the trustee of high value trust or other persons to whom such investment or investment activity may lawfully be made available (together, “Relevant Persons”). Persons who are not Relevant Persons should not take any action on the basis of this announcement and should not act or rely on it. Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the “MiFID II Product Governance Requirements”), and dis-claiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the securities that are the subject of the Offering have been subject to a product approval process, which has determined that such securities are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the “Target Market Assessment”). Notwithstanding the Target Market Assessment, distributors should note that: the price of the securities may decline and investors could lose all or part of their investment; the securities offer no guar-anteed income and no capital protection; and an investment in the securities is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Managers will only procure investors who meet the criteria of professional clients or eligible counterparties (except for a public offering to investors in Denmark conducted pursuant to a separate prospectus that has been approved by and registered with the Danish Financial Supervisory Authority. For the avoidance of doubt, the Target Market Assessment does not constitute: (i) an assessment of suitability or appropriateness for the purposes of MiFID II; or (ii) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to, the securities. Each distributor is responsible for undertaking its own target market assessment in respect of the Shares and determining appropriate distribution channels. THE CONTENTS OF THIS WEBSITE ARE NOT TO BE INCORPORATED INTO, OR CONSTRUED TO FORM PART OF, ANY OF THE DOCUMENTS INCLUDED HEREIN. EXCEPT AS OTHERWISE EXPLICITLY STATED HEREIN AS APPLICABLE TO THEM, NO INFORMATION INCLUDED ON THIS WEBSITE SHOULD BE USED BY INVESTORS IN FORMING THEIR INVESTMENT DECISION AS TO ANY SECURITIES.

OK